The funding will help Micron on their journey to expand internationally and to address the huge issue of overuse of anti-parasitic medication. We are looking forward to supporting the entire Micron team on their journey to revolutionize animal health through AI.
Having been part of the @atlanticbridgev team co-leading this round with @ElkstoneVenture and a fantastic syndicate of new and existing investors makes me feel having fully arrived in Ireland. #VentureCapital#investing#medtech
Delighted to have been part of the @republicofwork Deeptech Fest and talking about @atlanticbridgev role in catalyzing Deeptech spin-outs. It’s a great time to found new Irish Deeptech companies.
The highly requested panel discussion on “Fundraising in the Current Landscape is up next, on this panel we have @JustinaUgwah from Clisterprobe, @DomLei from @atlanticbridgev and @liaonet from @SOSV 💰
The highly requested panel discussion on “Fundraising in the Current Landscape is up next, on this panel we have @JustinaUgwah from Clisterprobe, @DomLei from @atlanticbridgev and @liaonet from @SOSV 💰
Delighted to have held the @atlanticbridgev & @Tyndall Deep Tech Spin-out Forum in Cork. Exciting discussion on the role Atlantic Bridge plays in catalysing Deep Tech spinout ideas from leading research centres in Ireland. This is an opportune time to found new #spinouts!
Great to be at today’s @Entirl Start-up Showcase. Even better, so many of @atlanticbridgev supported companies to be mentioned and presented. Great to be back at in person events again. #globalambition
A G4-selective transcription inhibitor supported by UCLTF and developed at @School_Pharmacy is moving forward to clinic in partnership with @QualigenInc.
Read more here: https://t.co/DSqy7Uw0pS
@UCL_Business@AlbionVC@UCLEnterprise
@es_arman @UCLTF@UCL_Business@UCLTRO@UCLBrainScience Will forward you the meeting details directly. Additionally, we asked FSB to recirculate the invite for everyone else within FSB to make sure everyone can join.
Looking forward giving another joint @UCLTF@UCL_Business@UCLTRO presentation on "Translational Research within UCL" tomorrow. This time open for all staff and students @UCLBrainScience.
Novalgen, a UCLTF portfolio company who develop breakthrough bispecific therapies to fight cancer, are presenting at the American Society of Clinical Oncology (ASCO) Annual meeting 2021. Read more here: https://t.co/KdfX1ALm1H
@UCL_Business@AlbionVC@UCLEnterprise